Browse by People

Collapse authors list.
Brummendorf, Tim H, Cortes, Jorge E, Milojkovic, Dragana, Gambacorti-Passerini, Carlo, Clark, Richard E ORCID: 0000-0002-1261-3299, le Coutre, Philipp, Garcia-Gutierrez, Valentin, Chuah, Charles, Kota, Vamsi, Lipton, Jeffrey H et al (show 9 more authors) , Rousselot, Philippe, Mauro, Michael J, Hochhaus, Andreas, Hurtado Monroy, Rafael, Leip, Eric, Purcell, Simon, Yver, Anne, Viqueira, Andrea and Deininger, Michael W (2022) Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: final results from the BFORE trial. , England.

Collapse authors list.
Patel, Amit ORCID: 0000-0003-0029-4611, Szydlo, Richard M ORCID: 0000-0003-1102-8298, Auner, Holger W ORCID: 0000-0003-4040-0642, Kanfer, Edward J, MacDonald, Donald H, Milojkovic, Dragana, Altaf, Syed, Innes, Andrew, Gabriel, Ian, Rahemtulla, Amin et al (show 5 more authors) , Chaidos, Aristeidis ORCID: 0000-0003-1453-8576, Karadimitris, Anastasios, Olavarria, Eduardo, Apperley, Jane F and Pavlů, Jiří (2018) C-reactive protein prior to myeloablative allogeneic haematopoietic cell transplantation identifies patients at risk of early- and long-term mortality. British journal of haematology, 180 (6). pp. 889-892.

Collapse authors list.
Clark, Richard E ORCID: 0000-0002-1261-3299, Polydoros, Fotios ORCID: 0000-0001-5181-6817, Apperley, Jane F, Milojkovic, Dragana, Pocock, Christopher, Smith, Graeme, Byrne, Jenny L, de lavallade, Hugues, O'Brien, Stephen G, Coffey, Tony et al (show 2 more authors) , Foroni, Letizia and Copland, Mhairi (2017) De-escalation of tyrosine kinase inhibitor dose in patients with chronic myeloid leukaemia with stable major molecular response (DESTINY): an interim analysis of a non-randomised, phase 2 trial. The Lancet Haematology, 4 (7). E310-E316.

Collapse authors list.
Clark, Richard E ORCID: 0000-0002-1261-3299, Polydoros, Fotios, Apperley, Jane F, Milojkovic, Dragana, Rothwell, Katherine, Pocock, Christopher, Byrne, Jennifer, de lavallade, Hugues, Osborne, Wendy, Robinson, Lisa et al (show 4 more authors) , O'Brien, Stephen G, Read, Lucy, Foroni, Letizia and Copland, Mhairi (2019) De-escalation of tyrosine kinase inhibitor therapy before complete treatment discontinuation in patients with chronic myeloid leukaemia (DESTINY): a non-randomised, phase 2 trial. The Lancet Haematology, 6 (7). E375-E383.

Claudiani, Simone, Apperley, Jane F, Gale, Robert Peter, Clark, Richard ORCID: 0000-0002-1261-3299, Szydlo, Richard ORCID: 0000-0003-1102-8298, Deplano, Simona, Palanicawandar, Renuka, Khorashad, Jamshid, Foroni, Letizia and Milojkovic, Dragana (2017) E14a2 <i>BCR-ABL1</i> transcript is associated with a higher rate of treatment-free remission in individuals with chronic myeloid leukemia after stopping tyrosine kinase inhibitor therapy. Haematologica, 102 (8). e297-e299.

Collapse authors list.
Copland, Mhairi, Slade, Daniel, McIlroy, Graham, Horne, Gillian, Byrne, Jenny L, Rothwell, Kate, Brock, Kristian, De Lavallade, Hugues, Craddock, Charles, Clark, Richard E ORCID: 0000-0002-1261-3299 et al (show 5 more authors) , Smith, Matthew L, Fletcher, Rachel, Bishop, Rebecca, Milojkovic, Dragana and Yap, Christina (2022) Ponatinib with fludarabine, cytarabine, idarubicin, and granulocyte colony-stimulating factor chemotherapy for patients with blast-phase chronic myeloid leukaemia (MATCHPOINT): a single-arm, multicentre, phase 1/2 trial. LANCET HAEMATOLOGY, 9 (2). E121-E132.

Collapse authors list.
Milojkovic, Dragana, Cross, Nicholas CP, Ali, Sahra, Byrne, Jenny, Campbell, Gavin, Dignan, Fiona L, Drummond, Mark, Huntly, Brian, Marshall, Scott, McMullin, Mary Frances et al (show 12 more authors) , Neelakantan, Pratap, Raghavan, Manoj, Sivakumaran, Muttuswamy, Tighe, Jane, Wandroo, Farooq, Willis, Fenella, Glen, Fiona, Fildes, Louise, Collington, Sarah J, Ryan, Jacqueline, Clark, Richard E ORCID: 0000-0002-1261-3299 and Mead, Adam J (2021) Real-world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study. BRITISH JOURNAL OF HAEMATOLOGY, 192 (1). pp. 62-74.

Collapse authors list.
Claudiani, Simone, Janssen, Jeroen JWM, Byrne, Jenny, Smith, Graeme, Blijlevens, Nicole, Raghavan, Manoj, Smith, Matthew, Clark, Richard E ORCID: 0000-0002-1261-3299, Mclain-Smith, Susan, Carter, Angela M et al (show 2 more authors) , Milojkovic, Dragana and Apperley, Jane F (2022) A retrospective observational research study to describe the real-world use of bosutinib in patients with chronic myeloid leukemia in the United Kingdom and the Netherlands. EUROPEAN JOURNAL OF HAEMATOLOGY, 109 (1). pp. 90-99.